IOVA - Company ID 0001425205
The table below shows IOVANCE BIOTHERAPEUTICS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $163.08M | $115.69M | $114.89M | $231.73M | $78.23M | $67.33M |
| Short-term investments | $133.90M | $208.09M | $164.98M | $240.11M | $426.18M | $562.11M |
| Receivables | $82.45M | $69.34M | $151.00K | - | - | - |
| Inventory | $51.68M | $51.52M | $10.37M | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $442.69M |
| $457.02M |
| $307.85M |
| $479.12M |
| $507.96M |
| $636.10M |
| Property, plant & equipment | $131.11M | $109.08M | $114.03M | $105.23M | $100.94M | $59.16M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $913.17M | $910.43M | $780.35M | $663.98M | $777.33M | $768.46M |
| Accounts payable | $22.16M | $27.51M | $33.12M | $26.60M | $27.38M | $13.51M |
| Total current liabilities | $138.36M | $122.34M | $110.31M | $91.48M | $89.20M | $54.87M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $214.59M | $200.02M | $195.74M | $164.34M | $155.67M | $111.96M |
| Retained earnings | -$2.78B | -$2.38B | -$2.01B | -$1.57B | -$1.17B | -$830.19M |
| Total equity | $698.58M | $710.40M | $584.61M | $499.64M | $621.66M | $656.50M |